These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


156 related items for PubMed ID: 12153803

  • 1. Successful treatment of serpiginous choroiditis with alkylating agents.
    Akpek EK, Jabs DA, Tessler HH, Joondeph BC, Foster CS.
    Ophthalmology; 2002 Aug; 109(8):1506-13. PubMed ID: 12153803
    [Abstract] [Full Text] [Related]

  • 2. Treatment of Serpiginous Choroiditis with Chlorambucil: A Report of 17 Patients.
    Ebrahimiadib N, Modjtahedi BS, Davoudi S, Foster CS.
    Ocul Immunol Inflamm; 2018 Aug; 26(2):228-238. PubMed ID: 27754769
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Interferon alpha-2a treatment for serpiginous choroiditis.
    Sobaci G, Bayraktar Z, Bayer A.
    Ocul Immunol Inflamm; 2005 Feb; 13(1):59-66. PubMed ID: 15804771
    [Abstract] [Full Text] [Related]

  • 5. Long-term immunosuppressive treatment of serpiginous choroiditis.
    Akpek EK, Baltatzis S, Yang J, Foster CS.
    Ocul Immunol Inflamm; 2001 Sep; 9(3):153-67. PubMed ID: 11815884
    [Abstract] [Full Text] [Related]

  • 6. Combination of azathioprine and corticosteroids in the treatment of serpiginous choroiditis.
    Vianna RN, Ozdal PC, Deschênes J, Burnier MN.
    Can J Ophthalmol; 2006 Apr; 41(2):183-9. PubMed ID: 16767205
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of chlorambucil in intractable noninfectious uveitis: the Massachusetts Eye and Ear Infirmary experience.
    Miserocchi E, Baltatzis S, Ekong A, Roque M, Foster CS.
    Ophthalmology; 2002 Jan; 109(1):137-42. PubMed ID: 11772593
    [Abstract] [Full Text] [Related]

  • 13. Clinical profile, treatment, and visual outcome of ampiginous choroiditis.
    Jyotirmay B, Jafferji SS, Sudharshan S, Kalpana B.
    Ocul Immunol Inflamm; 2010 Jan; 18(1):46-51. PubMed ID: 20128650
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy of reduced dose of intravitreal triamcinolone acetonide in a case of active serpiginous choroiditis.
    Ghose A, Bhende PS, Biswas J.
    Indian J Ophthalmol; 2016 Sep; 64(9):681-682. PubMed ID: 27853021
    [Abstract] [Full Text] [Related]

  • 17. Short-term Intensive Immunosuppression: A Randomized, Three-arm Study of Intravenous Pulse Methylprednisolone and Cyclophosphamide in Macular Serpiginous Choroiditis.
    Venkatesh P, Tayade A, Gogia V, Gupta S, Shah BM, Vohra R.
    Ocul Immunol Inflamm; 2018 Sep; 26(3):469-476. PubMed ID: 27849419
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Retrospective analysis of the natural history and management of serpiginous choroiditis in Australia and New Zealand.
    Toniolo J, Hall AJ, Sims J, Fraser-Bell S, Khan J, Younan C, Kent-Smith B, Young S, Paul E, Lim LL.
    Clin Exp Ophthalmol; 2014 Sep; 42(7):656-64. PubMed ID: 24330142
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.